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Most vaccinia virus intermediate and late mRNAs possess 3Vends that are extremely heterogeneous in sequence. However, late mRNAs
encoding the cowpox A-type inclusion protein (ATI), the second largest subunit of the RNA polymerase, and the late telomeric transcripts
possess homogeneous 3Vends. In the case of the ATI mRNA, it has been shown that the homogeneous 3Vend is generated by a post-
transcriptional endoribonucleolytic cleavage event. We have determined that the F17R gene also produces homogeneous transcripts
generated by a post-transcriptional cleavage event. Mapping of in vivo mRNA shows that the major 3Vend of the F17R transcript maps 1262
nt downstream of the F17R translational start site. In vitro transcripts spanning the in vivo 3Vend are cleaved in an in vitro reaction using
extracts from virus infected cells, and the site of cleavage is the same both in vivo and in vitro. Cleavage is not observed using extract from
cells infected in the presence of hydroxyurea; therefore, the cleavage factor is either virus-coded or virus-induced during the post-replicative
phase of virus replication. The cis-acting sequence responsible for cleavage is orientation specific and the factor responsible for cleavage
activity has biochemical properties similar to the factor required for cleavage of ATI transcripts. Partially purified cleavage factor generates
cleavage products of expected size when either the ATI or F17R substrates are used in vitro, strongly suggesting that cleavage of both
transcripts is mediated by the same factor.
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Introduction previous stage. Post-initiation events, viz., elongation andVaccinia virus, the prototypical orthopoxvirus, contains a
linear double-stranded genome of 192-kb that encodes
approximately 200 genes (Moss, 2001). Poxviruses are
unique among DNA viruses in that their entire replication
cycle occurs in the cytoplasm of the infected cell. Because
of this cytoplasmic site of infection, vaccinia encodes the
majority of the enzymes required for viral DNA replication
and transcription. Poxvirus transcription is temporally reg-
ulated. Early genes are transcribed before DNA replication,
whereas intermediate and late genes are transcribed after
DNA replication. At each stage, transcription initiation
requires trans-acting factors that are synthesized in the0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: condit@mgm.ufl.edu (R.C. Condit).termination of all three transcriptional classes, are also
regulated. Thus, vaccinia serves as a good model to study
the fundamental aspects of transcription.
Regulation of pre- and post-replicative RNA 3Vend
formation occurs by different mechanisms. At early times
during infection before DNA replication, viral transcripts
are relatively homogeneous in sequence both at their 5Vand
3Vends. This homogeneity at the 3Vend of early transcripts
results from a sequence-specific transcription termination
event controlled by a highly specific cis-acting sequence 5V
UUUUUNU3Vin the nascent RNA (Rohrmann et al., 1986;
Shuman and Moss, 1988; Yuen and Moss, 1987) and several
early termination factors (Christen et al., 1998; Deng and
Shuman, 1998; Mohamed and Niles, 2000; Shuman et al.,
1987). Upon transcription of this signal, the polymerase
terminates 30–50 nt downstream. The known virus-coded
termination factors include the heterodimeric capping en-
zyme (VTF) (Shuman et al., 1987), NPH-I (Christen et al.,
S.M. D’Costa et al. / Virology 319 (2004) 1–1121998), and RAP94 (Mohamed and Niles, 2000). By con-
trast, at late times post-infection following the onset of DNA
replication, both intermediate and late transcripts are ex-
tremely heterogeneous at their 3Vends (Mahr and Roberts,
1984). The cis-acting signal that is operative at early times is
not active even when present in late transcripts, and to date,
no cis-acting sequence has been identified that might be
involved in signaling the termination of intermediate and
late transcripts. If such a signal does exist, it must be highly
degenerate or very simple, and inefficient. However, it has
been shown both genetically and biochemically that the
products of vaccinia genes A18R, G2R, and J3R control 3V
end formation by influencing intermediate and late tran-
scription elongation and termination (Black and Condit,
1996; Lackner and Condit, 2000; Latner et al., 2000; Xiang
et al., 1998, 2000). The 56-kDa A18 protein is a transcript
release factor required for dissociation of nascent RNA from
a ternary transcription complex in vitro (Lackner and Con-
dit, 2000). In addition, viruses with mutations in A18R
produce abnormally long post-replicative transcripts in vivo
(Xiang et al., 1998). In contrast to the effect of A18, the 26-
kDa G2 and 39-kDa J3 proteins have been shown to be
positive elongation factors of post-replicative transcription
(Black and Condit, 1996; Condit et al., 1996b; Latner et al.,
2000, 2002; Xiang et al., 2000). Mutants in either of these
proteins produce post-replicative transcripts that are shorter
than normal at their 3Vends, resulting in reduced quantities
of large proteins at late times post infection (Black and
Condit, 1996; Xiang et al., 2000). In summary, although
intermediate and late transcripts are heterogeneous at their 3V
ends, suggesting a lack of sequence-specific termination, 3VFig. 1. Crude mapping of the 3Vend of the homogeneous F17R transcripts. (A) A d
3V end of F17R transcripts. The solid horizontal line represents the F17R and the
F17R promoter (PF17) and the E1L promoter (PE1L) and the orientation of these gen
numbers represent the sequence position in nucleotides downstream of the F17 tra
to show positions of four tandem oligonucleotides, a, b, c, and d, used to probe N
cells. (B) Northern analyses of total viral RNA using tandem oligonucleotide pro
times shown, transferred to nylon membranes, and hybridized with 32P labeled olig
positions of the four probes are indicated above the autoradiogram. M = RNA fro
infection are shown above each lane. Molecular weight standards are indicated oend formation of post-replicative transcripts is nevertheless
clearly influenced by viral-encoded factors.
Not all late transcripts are heterogeneous at their 3Vends.
Pickup et al. have identified at least three exceptions:
transcripts from the gene encoding the major protein com-
ponent of the A-type inclusion (ATI) bodies in cowpox and
vaccinia (Amegadzie et al., 1992; Patel and Pickup, 1987;
Patel et al., 1986, 1988), telomeric transcripts from cowpox,
raccoonpox, and vaccinia virus (Parsons and Pickup, 1990),
and transcripts from the gene encoding the second largest
subunit of RNA polymerase (rpo132) in vaccinia virus
(Patel and Pickup, 1989; Patel et al., 1988). In the case of
the ATI transcripts, 3Vend homogeneity is a result of post-
transcriptional site-specific endoribonucleolytic cleavage of
the nascent RNA (Antczak et al., 1992). The 3Vends of the
ati transcripts map within a 345-bp AluI–XbaI fragment
(AX element) contained within the coding region of the
convergently transcribed rpo132 gene (Patel and Pickup,
1987). Further analysis of homogeneous transcripts of the
ati gene revealed the presence of a 43-nt cis-acting element
that directs the cleavage reaction (Howard et al., 1999).
Interestingly, most of the cis-acting element is downstream
of the cleavage site. The cis-acting sequence is composed of
at least two noncontiguous regions with a spacer region of
10 bases whose composition may be changed without
interfering with RNA 3V end formation. Portions of the
two noncontiguous regions are complementary to each
other, suggesting the possibility that the two regions form
a specific structure that participates in 3Vend formation. The
factor responsible for cleavage of nascent ATI transcripts
appears to be virus-induced or coded at late times postiagram showing the map positions of oligonucleotides used to determine the
E1L genes in their entirety. Arrows on either side of the line represent the
es on the genome. The F17R and E1L ORFs are denoted as open boxes. The
nslation start site. The region between 1139 and 1325 nt has been expanded
orthern blots containing RNA from mock-infected or virus-infected BSC40
bes. RNA was extracted from mock-infected and wt virus-infected cells at
onucleotide probes a, b, c, or d. An autoradiogram is shown. The sequence
m mock-infected cells, Virus = RNA from virus-infected cells. Times after
n the right of the autoradiogram in kilobase.
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exceptions is not known at this time.
We have observed that yet another late gene, F17R,
yields homogeneous transcripts (1.4 kb) late during the
virus infection cycle. The object of this study was to identify
the 3V ends of these transcripts and to characterize the
mechanism of 3V end formation in F17R transcripts. We
demonstrate that F17R transcripts have a well-defined 3Vend
1262 nt downstream of the F17R translation start site. In
addition, these ends are formed by post-transcriptional
endoribonucleolytic cleavage of the nascent message. We
have also characterized and optimized the conditions of
F17R cleavage. Our results suggest that the same factor is
probably responsible for cleavage of both the ATI and F17R
transcripts.Fig. 2. Nuclease S1 protection analysis of the 3Vends of F17R RNAs. Total
RNA harvested from virus-infected cells at 12 h p.i. was incubated with a
32P-3V-end-labeled DNA oligonucleotide containing 1208–1287 nt down-
stream of the F17R translation start site. The RNA–DNA hybrids were
subjected to S1 nuclease digestion, denatured, and the nuclease-resistant
products were resolved on a 10% polyacrylamide-urea gel. An autoradio-
gram is shown. Lanes 1–4 correspond to the F17R sequence (G, A, T, C) in
this region. The 5Vend of the sequencing primer corresponds exactly with
the 3’ end of the labeled probe used in the S1 analysis. Lane 5 corresponds
to the S1 products. The full-length undigested probe is indicated. A portion
of the sequence containing the S1 products has been expanded on the left
with arrows indicating the position of the S1 products. The length of the
arrowheads corresponds to the intensity of the S1 products.Results
Crude mapping of the 3Vend of F17 transcripts
The vaccinia virus F17R gene is a late gene which
encodes an 11-kDa phosphoprotein present in the virion
core (Wittek et al., 1984). Homogeneous transcripts (1.4 kb)
of the F17 gene have been previously observed in our
laboratory in Northern blots using oligonucleotide probes
that span the downstream region of the F17R transcript
(Xiang et al., 2000). In these experiments, we localized the
3Vend of the wt F17R transcript to a region between 1160
and 1510 nt downstream of the F17 translational start site.
To obtain a more refined map position for the 3V end of
F17R transcripts, Northern blot analysis was carried out
using antisense DNA oligonucleotides (approximately 50
mers) that span the entire region between 1139 and 1536 nt
downstream of the F17R translation start site (Fig. 1).
Homogeneous F17R transcripts were clearly detected with
probes a–c. A weak, largely heterogeneous signal was
detected with probe d mainly at 6 h p.i. (Fig. 1). No signal
was detected with other probes spanning the regions
downstream of d (data not shown). Therefore, we con-
cluded that the 3Vends of the F17R transcript map
between 1226 and 1275 nt downstream of the F17R
translation start site. We suspect that the faint signal
detected with probe d represents a background of hetero-
geneous F17R transcripts similar to those produced by
most late genes.
Nuclease S1 mapping to determine the exact 3Vend of F17R
transcripts
Nuclease S1 mapping was used to precisely map the
F17R 3Vend within 1226–1275 nt downstream of the F17R
translation start site. Total RNA was extracted at late times
postinfection from virus-infected cells and hybridized to a
3V-end-labeled DNA oligonucleotide. The RNA–DNA
hybrids were then treated with nuclease S1, denatured,and fractionated on a polyacrylamide-urea gel (Fig. 2).
Lanes 1–4 correspond to F17R sequence (G, A, T, C) in
this region of the viral genome. Lane 5 contains the S1-
treated products showing about nine products of varying
intensity. This apparent 3Vend heterogeneity was observed
with varying S1 nuclease concentrations and hybridization
temperatures, strongly suggesting that there are in fact
multiple 3Vends within this region. An identical result was
obtained using poly(A) containing infected cell RNA (not
shown). The band with the highest intensity was 1262 nt
downstream of the F17R translation start site and was
therefore designated as the major 3Vend. Larger protected
products as well as undigested probe were also observed in
S.M. D’Costa et al. / Virology 319 (2004) 1–114lane 5. Consistent with the background observed with probe
d in Fig. 1, we suspect that these signals correspond to a
background of heterogeneous F17R transcripts similar to
those produced by most late genes.
The 3Vends of F17R transcripts are generated by
site-specific cleavage
The generation of 3Vends in F17R transcripts could be as
a result of transcription termination or post-transcriptional
endoribonucleolytic cleavage of nascent transcripts. The 3V
end of the ATI transcript is formed by post-transcriptional
endoribonucleolytic cleavage (Antczak et al., 1992). To
determine if the same mechanism was responsible for the
homogeneity of F17R transcripts, we used an adaptation of
the in vitro cleavage assay reported earlier (Antczak et al.,
1992) and described in detail in Materials and methods (Fig.
3). RNA containing the F17R in vivo 3Vend was synthe-
sized in vitro as a 430-nt transcription product from clone
pGF17stp DNA using SP6 polymerase (Fig. 3A; Substrate
1). The 430-nt transcript was incubated for various times at
30 jC with extracts from cells infected or mock-infected in
the presence or absence of hydroxyurea, a known DNA
synthesis inhibitor (Fig. 3B). When the 430-nt transcript
was treated with an extract from cells infected in the absenceFig. 3. 3V ends in F17R transcripts are generated by post-transcriptional endoribon
1 and 2 used in the in vitro cleavage assay. The solid horizontal line represents the
represent the F17R promoter (PF17) and the E1L promoter (PE1L) and the orientati
open boxes. The numbers represent the sequence position in nucleotides downstre
transcripts in vivo are shown as solid arrows. L = late F17R transcript, E = early E
the F17L transcript. Substrates 1 and 2 indicate the in vitro transcripts used in th
denoted by solid horizontal lines. Substrate 1 also contains 49 nt of vector sequenc
not shown in this cartoon. (B) Autoradiograph of an in vitro cleavage assay using t
(430 nt) was incubated at 30 jC with extracts from cells infected (Virus + HU, Vir
absence of hydroxyurea (HU) for various times. Times of incubation in minutes a
incubated in the absence of extract (No Extract) or loaded directly on the ge
polyacrylamide-urea gel. Molecular weight markers are shown on the right in ba
transcript of Substrate 2. 32P-labeled sense transcript of Substrate 2 (410 nt) was in
extracts (Extract 1, Extract 2, and Extract 3), in the absence of extract (No Extrac
samples and fractionated on a 6% polyacrylamide-urea gel. Molecular weight maof drug, two RNA products of approximately 190 and 240
nt were observed. Similar products were not evident with
extracts from cells infected in the presence of hydroxyurea,
mock-infected, and in the absence of any extract. These
results show that the 3V ends of F17R transcripts are
produced by post-transcriptional cleavage of nascent
RNA, and that the factor responsible for this activity is
either virus-coded or virus-induced late during infection.
Cleavage of ATI transcripts was only observed with extracts
from cells infected in the absence of AraC, suggesting that
the factor responsible for post-transcriptional cleavage of
nascent ATI transcripts is also virus-induced or virus-coded
late during infection (data not shown). Extracts from puri-
fied virus particles did not cleave either the F17R or the ATI
transcripts (data not shown).
Products of 190 and 240 nt could result from a cleavage
event of Substrate 1 at one of two sites referred to here as an
upstream or downstream cleavage event. An upstream
cleavage event would coincide with the in vivo cleavage
site. A downstream cleavage event would coincide with
cleavage 50 nt downstream from the in vivo cleavage site.
To determine if the 3Vend observed in vitro was the same as
that observed in vivo, we used a second RNA, 410 nt long,
transcribed in vitro using T7 polymerase from clone
pGF17sense609 DNA digested with AccI (Substrate 2). Ifucleolytic cleavage. (A) A diagram showing the map positions of Substrates
F17R and the E1L genes in their entirety. Arrows on either side of the line
on of these genes on the genome. The F17R and E1L ORFs are denoted as
am of the F17R translation start site. The orientation of the F17R and E1L
1L transcript. The vertical dotted line indicates the in vivo cleavage site for
e cleavage assay. The vaccinia sequences present in Substrates 1 and 2 are
e at the 5Vend and Substrate 2 contains 9 nt of vector sequence at the 5Vend
he sense transcript of Substrate 1. 32P-labeled sense transcript of Substrate 1
us  HU) or mock-infected (Mock + HU, Mock  HU) in the presence or
re shown above each lane. A corresponding amount of Substrate 1 was also
l ( ). RNA was purified from the reactions and fractionated on a 6%
se pairs. (C) Autoradiograph of an in vitro cleavage assay using the sense
cubated at 30 jC for 60 min with three independently prepared infected-cell
t), or loaded directly on the gel (Substrate 2). RNA was purified from these
rkers are shown on the right in base pairs.
Fig. 4. The cis-acting sequence required for 3Vend formation in F17R is
strand-specific. 32P-labeled sense (430 nt) or antisense (402 nt) transcripts
of Substrate 1 were incubated at 30 jC for 60 min with three independently
prepared infected-cell extracts (Extract 1, Extract 2, and Extract 3), in the
absence of extract (No Extract), or loaded directly on the gel (Substrate).
RNA was recovered from the samples and fractionated on a 6%
polyacrylamide-urea gel. Molecular weight markers are indicated on the
right in base pairs.
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products would be 164 and 246 nt long. If, however, a
downstream cleavage site was used, the expected productsFig. 5. Biochemical characterization of cleavage activity. (A) Effect of salt and Mg
nt) of Substrate 1 was incubated with 20 Ag of infected-cell extract at 30 jC for 6
RNAwas recovered from these samples and fractionated on a 6% polyacrylamide
mM MgCl2) are indicated above each lane. Molecular weights are indicated to
concentration on cleavage activity. The 32P-labeled sense transcript of Substrate 1
in the absence of extract (0). Extract concentration is indicated above each lane in
Time course of cleavage activity. The 32P-labeled sense transcript of Substrate 1 w
in the absence of extract (No Extract). Time in minutes is indicated above each lan
D–G are computed with data from A–C. Percentage of cleavage over backgroun
minutes (G).would be 200 and 210 nt long. The transcript of Substrate 2
was incubated with three independent preparations of
infected-cell extracts. Fractionation of this RNA on poly-
acrylamide gels revealed the presence of two RNA products
approximately 160 and 250 nt long in addition to the full-
length substrate (Fig. 3C). These results confirm that the 3V
ends of F17R transcripts are synthesized as a result of post-
transcriptional cleavage of the nascent RNA and that the site
of cleavage is the same both in vivo and in vitro.
The cis-acting sequence required for site-specific cleavage
is strand specific
The generation of 3Vends in F17R transcripts must re-
quire a cis-acting recognition signal for site-specific cleav-
age. A 43-nt cis-acting element has been characterized at the
3Vend of ATI transcripts to be responsible for site-specific
cleavage (Howard et al., 1999). Most of this sequence was
observed to be downstream of the cleavage site. The reverse
complement of this sequence was inactive in cleavage. To
determine if the cis-acting sequence in F17R transcripts has
similar characteristics as the ATI cis-acting sequence, we
incubated either sense or antisense transcripts from Sub-
strate 1 with three independent preparations of infected-cell
extracts (Fig. 4). Expected cleavage products of 190 and 2402+ concentration on cleavage activity. The 32P-labeled sense transcript (430
0 min in the absence or with increasing concentrations of NaCl or MgCl2.
-urea gel. An autoradiograph is shown. The molar concentrations (M NaCl,
the left in base pairs. (B) Autoradiograph showing the effect of extract
was incubated at 30 jC for 60 min with increasing extract concentrations or
Ag. Molecular weight markers are indicated on the right in base pairs. (C)
as incubated at 30 jC with 20 Ag of infected-cell extract for various times or
e. Molecular weight markers are indicated to the right in base pairs. Graphs
d is plotted versus M NaCl (D), mM MgCl2 (E), Ag extract (F), or time in
S.M. D’Costa et al. / Virology 319 (2004) 1–116nt were obtained using the 430-nt sense transcript of
Substrate 1. The expected cleavage products with the 402-
nt antisense transcript would be 152 and 250 nt if cleavage
were not strand-specific. However, no cleavage products
were detected when the antisense transcript was used. These
results show that the cis-acting sequence required for
cleavage is indeed strand specific.
Biochemical characterization of the cleavage activity
The data described above suggest that the factor(s)
responsible for post-transcriptional cleavage of nascent
F17R transcripts are virus-coded or virus-induced at late
times during infection. To determine the biochemical char-
acteristics of this activity, the effect of NaCl, MgCl2, and
extract concentration was titrated, and a time course was
performed (Figs. 5A–C). Graphs of percentage of cleavage
over background were plotted using these data (Figs. 5D–
G). An obvious requirement of NaCl for cleavage activity
was noted, with an optimal concentration of 200 mM (33%
cleavage activity, Figs. 5A and D). The optimal salt con-
centration using any given extract preparation was slightly
different and ranged between 0.2 and 0.3 M NaCl (data not
shown). Higher concentrations of salt inhibited cleavage
activity. Other salts (KCl, NH4OAc, NH4Cl) were also
tested to determine the ideal salt for maximal activity (not
shown). While cleavage activity was detected in the pres-
ence of all these salts, the activity was maximal using NaCl.
The cleavage reaction also required Mg2+, with an optimalFig. 6. The factor responsible for cleavage of F17R and ATI transcripts may be the
transcript. 32P-labeled sense transcript of p2098 (2.7 kb) was incubated at 30 jC
(Extract), DEAE flowthrough fraction (DEAE), an eluate from an SP sepharose co
gel (Substrate). RNA was purified from these samples and fractionated on a 6%
denoted to the right of the autoradiograph in kilobase. (B) Autoradiograph of an i
reaction conditions and the extracts or fractions used to assay cleavage are the same
of the autoradiograph in base pairs.concentration between 5 and 10 mM (37% cleavage activity,
Figs. 5A and E). Cleavage activity increased linearly with
increasing concentrations of extract up to 20 Ag (26%
cleavage, Figs. 5B and F). Cleavage activity also increased
with time up to 120 min (33% cleavage, Figs. 5C and G).
Cleavage products were observed as early as 1 min. At 120
and 240 min, two additional cleavage products were ob-
served which were slightly smaller compared to each of the
original two products. We suggest these additional products
are the result of a nonspecific nuclease activity. Cleavage
activity is not stimulated by added ATP and not inhibited by
added AMP-PNP and therefore is not ATP dependent (not
shown).
The factor responsible for cleavage of the F17R and ATI
transcripts may be the same
The biochemical properties (effect of NaCl concentra-
tion, Mg2+ dependency, and the lack of requirement for
ATP) of the factor cleaving the F17R transcripts are the
same as those of the factor shown to cleave the ATI RNAs
(data not shown). To determine if the factor responsible for
endoribonucleolytic cleavage of F17R and ATI transcripts
may be the same, we incubated either the ATI transcript
(Antczak et al., 1992) or the F17R transcript from Substrate
1 with fractions from three steps of a purification protocol
currently under development in our laboratory (Fig. 6). The
fractions tested include a crude extract prepared from
infected HeLa cells (Extract), a 400 mM NaCl DEAEsame. (A) Autoradiograph of an in vitro cleavage assay using the ATI sense
for 60 min with crude extract prepared from wt-infected HeLa S3 cells
lumn (SP), in the absence of extract (No Extract), or loaded directly on the
polyacrylamide-urea gel. Molecular weights of each individual band are
n vitro cleavage assay using the F17 sense transcript from Substrate 1. The
as in A. Molecular weights of each individual band are denoted to the right
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fractions from an SP sepharose column eluting between 300
and 750 mM NaCl (SP). The expected cleavage products of
1.6 and 1.1 kb for the 2.7-kb ATI transcript (Antczak et al.,
1992) were observed with the crude infected HeLa cell
extract as well as with partially purified preparations of this
extract (Fig. 6A). These same fractions also cleaved the F17
sense transcript (Fig. 6B). No cleavage products were
observed for either substrate in the absence of any extract.
This result strongly suggests that the factor responsible for
cleavage of F17 transcripts is possibly the same as that for
ATI transcripts.Discussion
F17R provides yet another example of a late vaccinia
gene that produces homogeneous transcripts. Our results
demonstrate that F17R transcripts have a defined 3Vend,
1262 nt downstream of the F17R translational start site,
generated by site-specific endoribonucleolytic cleavage of
nascent mRNA. Homogeneous (1.4 kb) F17R transcripts
were observed in Northern analyses using poly(A) RNA
(not shown) as well as with total RNA, and S1 nuclease
protection assays with poly(A) RNA (not shown) showed
results similar to those observed with total RNA, demon-
strating polyadenylation of the cleaved F17R RNA 3Vend.
The cleavage factor is either virus-induced or virus-coded at
late times during infection and requires divalent cation and
salt for activity. The cis-acting sequence responsible for
cleavage is strand-specific and the factor responsible for
cleavage activity has similar biochemical properties as the
factor required for cleavage of ATI transcripts. Partially
purified cleavage factor generated cleavage products of
expected size when either the ATI or F17R substrates were
used in vitro, strongly suggesting that cleavage of both
transcripts is mediated by the same factor.
The cis-acting sequence identified in ATI transcripts is 43
nt long and composed of at least two noncontiguous regions
separated by a spacer of 10 bases (Howard et al., 1999). The
sequence composition of the spacer can be changed without
affecting 3Vend formation. Most of the cis-acting sequence
is downstream from the cleavage site. Portions of the
noncontiguous regions of the ATI cis-acting sequence are
complementary to each other, suggesting the formation of a
secondary structure that is necessary for cleavage. Using the
RNA fold program (Zuker et al., 1991) and partial ribonu-
clease digestion of a 260-base RNA transcript within the
AX element containing the 3V end of ATI, Howard et al.
(1999) identified a possible secondary structure for the ATI
substrate. However, the computer-assisted folding was not
completely supported by the partial RNase digestion, sug-
gesting that the two sub-elements are not directly associated
with each other but perhaps require the presence of other
factors involved in RNA 3Vend formation. A comparison of
the 43 nt cis-acting sequence identified in ATI with se-quence surrounding the cleavage site in F17R did not show
any obvious sequence homology. Furthermore, computer-
assisted folding of the 3V end of F17R does not yield
secondary structures for the cleavage sequence that are
obviously homologous to secondary structures proposed
for the ATI cleavage sequence. We assume that there must
exist some sequence or structure in common between the
F17R and ATI transcripts which directs the site-specific
RNA cleavage; however, our inability so far to identify any
homology between the F17R and ATI cleavage sites sug-
gests that these common features are extremely subtle.
It is unclear whether the cleavage reaction is confined to
just the ATI and F17R transcripts, or to the few late tran-
scripts that possess homogeneous 3Vends, or whether it
might be more generally involved in post-replicative RNA
3Vend formation. The majority of post-replicative vaccinia
transcripts are extremely 3Vend heterogeneous in sequence
(Mahr and Roberts, 1984). However, at least four late
poxvirus genes produce homogeneous transcripts, including
the ATI transcripts (Amegadzie et al., 1992; Patel and
Pickup, 1987; Patel et al., 1986, 1988), the telomeric tran-
scripts (Parsons and Pickup, 1990), transcripts from the
rpo132 gene (Patel and Pickup, 1989; Patel et al., 1988),
and transcripts from the F17R gene. Clearly, the exceptional
homogeneity found for late transcripts of ATI (Antczak et
al., 1992) and F17R is attributable to post-transcriptional
site-specific cleavage of the nascent RNA. It seems likely
that the cleavage factor described here is also responsible for
the RNA 3V end maturation of the other characterized
homogeneous transcripts. While the heterogeneity of most
other late vaccinia transcripts suggests a different mecha-
nism of 3V end formation compared to F17R and ATI
transcripts, it is also possible that post-transcriptional endor-
ibonucleolytic cleavage of nascent mRNAs represents the
mechanism by which all late mRNAs are produced. Specif-
ically, the cis-acting signal responsible for cleavage may be
highly degenerate and inefficient resulting in heterogeneous
3Vends for most transcripts. It also remains to be determined
whether termination of nascent RNA from the ternary
transcription complex, site-specific cleavage of the nascent
transcript, and polyadenylation are linked as is the case in
eukaryotic systems.
A precedent exists for a requirement of endoribonucleo-
lytic cleavage in the formation of Pol II transcripts in
eukaryotes. In eukaryotes, two distinct cleavage events are
required for the formation of mature mRNA (Dye and
Proudfoot, 2001; reviewed in Proudfoot et al., 2002). An
initial cleavage event, termed co-transcriptional cleavage
(CoTC), occurs at the region of Pol II termination down-
stream of the poly(A)-recognition signal. CoTC is followed
by a second cleavage event [termed here ‘‘poly(A) cleav-
age’’ for convenience] at the poly(A) site, followed by
polyadenylation and ultimately resulting in formation of
mature mRNA and release of the polymerase from the
DNA template. The initial CoTC event requires that the
polymerase traverse past the poly(A) signal. The polymerase
S.M. D’Costa et al. / Virology 319 (2004) 1–118then slows down or pauses in an AT-rich region downstream
of the poly(A) site and a primary CoTC event occurs at this
AT-rich region. The efficiency of the AT-rich elements
appears to differ in different genes; for example, a more
diffuse AT-rich signal exists in human q-globin transcripts as
compared to human h-globin transcripts (Dye and Proud-
foot, 2001). Following CoTC, the 5V proximal cleavage
product remains associated with the C-terminal domain
(CTD) of Pol II. The RNA polymerase remains associated
with the transcriptional complex and possibly traverses
further downstream with the 5Vproximal cleavage product
still associated with the CTD. Formation of the mature 3V
end of eukaryotic mRNA, release of the transcript from the
polymerase, and release of the polymerase from the tran-
scription complex involves a second cleavage event, the
poly(A) cleavage. Two cis-acting sequences on the primary
transcript and many trans-acting proteins are required for
poly(A) cleavage. The cis-acting sequences are (1) the
poly(A)-recognition signal, AAUAAA, 20–30 nt upstream
of the poly(A) cleavage site and (2) a GU-rich region
immediately downstream of the poly(A) cleavage site. These
sequences are recognized by two trans-acting factors: (1)
CPSF, the cleavage and polyadenylation specificity factor
and (2) CstF, the cleavage stimulation factor. These factors
then associate with two additional cleavage factors, CF1 and
CF2, and cleave the nascent RNA. The 5Vproximal cleaved
product is immediately polyadenylated by the poly(A)
polymerase, PAP. In addition to these processing factors,
the phosphorylated CTD of Pol II is also required for 3Vend
processing (reviewed in Proudfoot, 2000; Proudfoot and
O’Sullivan, 2002; Proudfoot et al., 2002). Interaction of the
5Vproximal cleavage product with the CTD and 3Vend
processing of this transcript at the poly(A) cleavage site
may have a role in mediating release of the polymerase, the
final step of termination. In summary, although Pol II
transcription termination determines the 3Vend of the prima-
ry transcript, the 3Vend of the mature transcript is formed by
RNA processing at the poly(A) cleavage site upstream of the
termination site. Both CoTC and poly(A) cleavage are
ultimately required for transcription termination.
Whether 3V end formation in post-replicative vaccinia
transcripts involves a similar elaborate and complex array of
protein–protein and protein–RNA interactions is yet to be
determined. It is tempting to postulate that a reaction similar
to the eukaryotic CoTC also occurs in all vaccinia late
genes. The heterogeneity of most late vaccinia transcripts
could then be attributed to the presence of diffuse cleavage
elements in the termination region. However, it seems
unlikely that polyadenylation and 3V end formation in
vaccinia late transcripts are linked, given that the sequence
requirements for the vaccinia poly(A) polymerase to poly-
adenylate 3Vends of mRNAs are more degenerate and less
specific (Gershon, 1998) than its eukaryotic counterpart. In
addition, homologs of CPSF, and CstF proteins have not
been identified in vaccinia. Ultimately, determination of the
role of the vaccinia ATI/F17R cleavage factor in viralmRNA metabolism will require identification of the gene(s)
encoding the cleavage factor, and study of mutations in the
cleavage factor gene(s). Experiments dedicated to this goal
are in progress.Materials and methods
Eukaryotic cells, viruses, and bacterial hosts
BSC40 cells, A549 cells, wild-type vaccinia strain WR,
and the conditions for their growth and infection have been
described previously (Condit and Motyczka, 1981; Condit
et al., 1983, 1996a). Escherichia coli TB1 cells were used in
transformations of pGF17stp, pGF17sense609, and p2098
plasmids.
Plasmids
pGF17stp contains vaccinia DNA from 1147 to 1466 nt
downstream of the F17R (gene VACV-WR 056) ATG start
site. This region was PCR amplified from the vaccinia WR
genome using forward primer 5VCGGGATCCAGTACT-
AGAATATCTATATCGCCG3Vand reverse primer 5VCG-
GAATTCCTACTTTTCTAAACAGAC3V, digested with
EcoRI and BamHI, and cloned into the corresponding sites
of pGEM-3zf(+) such that transcription from the T7
promoter would yield RNA which is antisense to the
F17R transcript although transcription from the SP6
promoter would yield sense transcripts in vitro.
pGF17sense609 contains vaccinia DNA from 1111 to
1696 nt downstream of the F17R start site. This region
was also PCR amplified from the vaccinia genome using
forward primer 5V CGGAATTCTCTAGAATTAGT-
CTGAAGAA3V and reverse primer 5V CGGGATCCAG-
TACTAGATTATAGAAACCTATTTA3V, digested with
EcoRI and BamHI, and cloned into pGEM-3zf(+) such that
transcripts sense to the F17R transcripts could be synthe-
sized from the T7 promoter. Plasmid p2098, which contains
the 3Vend of ATI transcript, has been previously described
(Antczak et al., 1992).
In vitro transcription
pGF17stp was linearized with EcoRI to generate a 430-nt
substrate in the sense orientation relative to F17R transcripts
or with XbaI to generate a 402-nt substrate antisense to F17R
transcripts. pGF17sense609 was linearized with AccI to
synthesize a 410-nt substrate in the sense orientation relative
to F17R transcripts. DNA from the p2098 clone was linear-
ized with NcoI to synthesize a 2.7-kb substrate in the sense
orientation relative to ATI transcripts. To synthesize RNA
substrates, 1 Ag of linearized DNA template was incubated
for 60 min at room temperature in a 20-Al reaction using a
MAXIScript SP6/T7 kit (Ambion) with either T7 (anti-
sense transcript from pGF17stp, sense transcript from
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RNA polymerase (sense transcript from pGF17stp). The
DNA template was then removed from the reaction by
digestion with 1 unit of RNase-free DNase (Ambion) at 37
jC for 15 min. The RNA substrate was then recovered by
phenol–chloroform extraction and concentrated by ethanol
precipitation in the presence of 2MNH4-acetate. The specific
activity of the sense and antisense transcripts from pGF17stp
and the sense transcript from pGF17sense609 was approxi-
mately 5  107 cpm/pmol RNA. The specific activity of the
ATI transcript from p2098 was approximately 4  108 cpm/
pmol RNA.
Northern analyses
Confluent 100-mm dishes of BSC40 cells were either
mock-infected or infected with wt vaccinia virus at an moi of
15 and incubated at 37 jC for 6, 8, and 12 h p.i. At the various
times postinfection, total RNAwas extracted from cells using
the RNeasy kit (Qiagen). Two micrograms of each sample
was then fractionated on a 1.2% agarose gel containing 2.2M
formaldehyde. Northern blotting and transfer were done
using established procedures (Ausebel et al., 1994). The
transferred RNA was cross-linked onto GeneScreen mem-
brane (NEN Life Sciences) with a StrataLinker 2400 (Stra-
tagene). Tandem oligonucleotides to be used as probes were
synthesized by Genemed Syn (CA). The positions of these
nucleotides in the WR genome (GenBank accession ,
AY243312) are 44893-44840 (probe a), 44926-44862 (probe
b), 44976-44927 (probe c), 45020-44974 (probe d), 45076-
45020, 45126-45073, 45186-45126, and 45238-45185. The
probes were 5V-end-labeled with [g-32P] ATP using T4 kinase
(New England Biolabs). Unincorporated nucleotides were
removed using a 1-ml G25 Sephadex column. Hybridization
was carried out at 42 jC using the protocol described by
Ausebel et al. (1994) with some modifications. The prehy-
bridization and hybridization solutions contained 6 SSC,
0.1% SDS, 10 Denhardt’s [50 Denhardt’s is 1% (w/v)
Ficoll 400, 1% (w/v) BSA (Sigma, Fraction V), and 1% (w/v)
polyvinylpyrrolidone], and 100 Ag single-stranded salmon
sperm DNA. After hybridization, the membrane was washed
twice in 5 SSC, 0.1% SDS at 50 jC for 20min each, blotted
dry, and exposed to X-ray film.
Preparation of infected cell extracts
Confluent 100-mm dishes of A549 cells were either
mock-infected or infected with wt vaccinia virus at an moi
of 15 and incubated at 37 jC for 16–18 h in the presence or
absence of 10 mM hydroxyurea. Extracts were prepared as
described previously (Condit et al., 1996a). Briefly, infected
cell monolayers were permeabilized with lysolecithin, har-
vested, treated with micrococcal nuclease, clarified by
centrifugation, and stored in aliquots at  70 jC. Total
protein concentration was determined using the Bradford
protein assay (Bio-Rad). Partially purified infected extractsused in Fig. 6 were from a purification procedure, which is
currently in progress in our laboratory, the details of which
will be published later. Briefly, suspension HeLa cells were
infected with vaccinia virus for 16 h, and the cells were
harvested by centrifugation, lysed by dounce homogeniza-
tion, and separated into nuclear and cytoplasmic fractions by
centrifugation. Most of the cleavage activity was associated
with the nuclear fraction. A high salt, sonicated, clarified
extract of the nuclear fraction, called ‘‘Extract’’ in Fig. 6,
was used for further purification. This extract was passed
over a column of DEAE cellulose at 400 mM NaCl, and the
flowthrough from this column that contains the cleavage
activity is called ‘‘DEAE’’ in Fig. 6. The DEAE fraction
was applied to an SP sepharose column and eluted with a
NaCl gradient. Active fractions eluting between 300 and
750 mM NaCl are called ‘‘SP’’ in Fig. 6.
RNA cleavage assays
32P-labeled RNA substrates prepared by in vitro tran-
scription were used in the RNA cleavage assays at 1000 or
10000 cpm per reaction. Assays were typically carried out
at 30 jC for 60 min in the presence of 20 Ag infected cell
extract, 40 mM Tris–HCl, pH 7.5, 300 mM NaCl, and 7.5
mM MgCl2 in a final volume of 25 Al. Samples were then
treated with 125 Al of ‘‘PK mix’’ (114 mM Tris–HCl, pH
7.5, 14 mM EDTA, 171 mM NaCl, 1.14% SDS, 40 Ag
glycogen, 230 Ag proteinase K) at 37 jC for at least 15 min,
followed by a single extraction with 150 Al phenol–chlo-
roform. RNA was precipitated by addition of 40 Al 10 M
NH4-acetate and 500 Al of ethanol, incubated at  20 jC for
10 min, and centrifuged at maximum speed (16000  g) for
30 min. Pellets were washed once with 70% ethanol, dried,
and resuspended in 10 Al formamide loading buffer. Sam-
ples were denatured at 90–95 jC for 3 min and loaded on a
6% polyacrylamide gel containing 8 M Urea (Sequagel,
National Diagnostics). Gels were fixed, dried, and visual-
ized by autoradiography. DNA ladders (50 bp, Gibco BRL)
were end-labeled with 32P [ATP] using polynucleotide
kinase and used as molecular weight markers. Cleavage
activity was calculated as the ratio of the sum of the
intensities of the two cleavage products to the sum of the
intensities of the uncleaved substrate and the products of
cleavage. This number was then corrected for background,
multiplied by 100, and denoted as percentage of cleavage.
Nuclease S1 assays
BSC40 cells were infected with wt vaccinia virus at an
moi of 15 and RNA was extracted at 12 h p.i. as for
northerns. The DNA oligonucleotide, corresponding to
44998–44931 nt in the WR genome, used to detect the 3V
ends of the F17R RNAwas labeled at the 3Vend with [a-32P]
(cordycepin-5V-triphosphate) (NEN) using terminal deoxy-
nucleotidyl transferase (Promega). Briefly, 10 pmol of
primer were incubated with 125 ACi [a-32P] (cordycepin-
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transferase at 37 jC for 30 min. The reaction was stopped by
heating at 70 jC for 10 min and the radiolabeled probe was
purified by phenol–chloroform extraction, and precipitated
in the presence of 2 M NH4-acetate and 20 Ag glycogen with
2.5 volumes of ethanol. Pellets were washed with 70%
ethanol, dried, and resuspended in 20 Al DEPC-treated water.
The denatured probe (106 cpm) was hybridized with 10 Ag
RNA in 30 Al buffer containing 1 M NaCl, 0.15 M HEPES,
pH 7.5, and 0.3 mMEDTA, pH 8, heated to 75 jC for 10 min,
and then incubated at 42 jC overnight. RNA–DNA hybrids
were digested with 75 units of nuclease S1 (Promega) in 300
Al of S1 buffer (0.28 M NaCl, 50 mM NaOAc, pH 4.5, 4.5
mM ZnSO4) and 6 Ag single-stranded salmon sperm DNA at
37 jC for 30 min. At the end of the incubation, the reaction
was stopped by adding 3 Al of 0.5 M EDTA, 20 Ag of
glycogen was added as carrier and the nuclease-resistant
products were precipitated with 700 Al ethanol. Pellets were
washedwith 70% ethanol, dried, and resuspended in 10 Al 0.1
M NaOH. Three microliters of nuclease resistant products
were combined with an equal volume of formamide loading
dye, heated at 90 jC for 3 min, and electrophoresed on a 10%
polyacrylamide gel containing 8 M Urea alongside a DNA
sequencing ladder. The gels were fixed, dried, and visualized
by autoradiography. The DNA ladder used to determine the 3V
end of the protected fragment after nuclease S1 digestion was
sequenced using the Sequenase v2.0 kit (USB Corporation).
The 5Vend of the primer (5V TGGCGTCTAAGATATT-
CTTCC3V) used for sequencing was designed to be comple-
mentary to the 3Vend of the labeled oligonucleotide probe.Acknowledgments
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